Institutional investors purchased a net $239.0 thousand shares of SRPT during the quarter ended September 2015, and now own 59.22% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREATIVE PLANNING, INC. Bought 25.9 Thousand shares of Sarepta Therapeutics Inc